Search Results 531-540 of 16053 for pharmacogenetics
Rosa Rademakers, Ph.D. The anomaly also turns up in more than 25 percent of patients with frontotemporal dementia (FTD). The finding has prompted a wide array ...
The purpose of this study is to collect patient and family DNA and disease data to learn more about how changes in certain genes may be linked to cancer.
Mayo Clinic's IBD Biobank Study collects biological samples & medical information to advance research on inflammatory bowel disease, Crohn's disease & other ...
In a prospective, multisite study, 15.2% of patients with pancreatic cancer were found to have a genetic predisposition to this deadly disease.
The purpose of this study is to evaluate whether the combination of durvalumab plus lurbinectedin can increase 6 month progression-free survival, in patients ...
The goals of the study are to prospectively evaluate clinical and laboratory biomarkers of multiple system atrophy and Parkinson's disease at early clinical ...
The purpose of this study is train and test classifiers for lung cancer detection using the DELFI assay and other biomarker and clinical features. Participation ...
The purpose of this study is to learn more about how individual women metabolize and respond to specific medications such as Naproxen and other NSAIDS. The way ...
Research curriculum for the PGY-2 Pharmacy Residency in Ambulatory Care at Mayo Clinic Health System in Mankato, Minnesota.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.